2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE Basic information
- Product Name:
- 2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE
- Synonyms:
-
- 2-PIPERAZINYL-4-AMINO-6,7-DIMETHOXYQUINAZOLINEHCL
- 4-Amino-2-piperazin-6,7-dimethoxyquinolinehydrochloride
- 2-Piperazinyl-6,7-dimethoxyquinazolin-4-amine hydrochlorode
- Piperazine amino dimethoxy quinaoline hydrochloride
- 2-Piperazine-4-amino-6,7-dimethoxy quinazoline HCl
- 2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE
- 2-Piperazinyl-4-amino-6,7-dimethoxyquinazoline Hydrochloride
- 2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINAOLINE HYDROCHLORIDE
- CAS:
- 84050-22-6
- MF:
- C14H20ClN5O2
- MW:
- 325.79
- Mol File:
- 84050-22-6.mol
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE Chemical Properties
- CAS DataBase Reference
- 84050-22-6(CAS DataBase Reference)
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE Usage And Synthesis
Uses
DPQ hydrochloride is a blood-brain barrier permeable and selective PARP-1 inhibitor that blocks PARP-1-mediated DNA damage repair and NAD+/ATP consumption, thereby inhibiting excessive inflammatory responses. DPQ hydrochloride inhibits NF-κB pathway activation, reduces the expression of pro-inflammatory factors (such as TNF-α, IL-6) and oxidative stress. DPQ hydrochloride can be used in inflammation-related studies of acute lung injury, myocardial infarction, and neurodegenerative diseases[1][2][3].
in vivo
DPQ hydrochloride (10 mg/kg; intraperitoneal injection; single dose; 6 h) significantly attenuates lung inflammation, neutrophil infiltration, and vascular leakage in LPS-induced acute lung injury model of C57BL/6 mice, inhibiting NF-κB pathway activation[2].
DPQ hydrochloride (10 mg/kg; intraperitoneal injection; single dose; 4 weeks) improves cardiac function and reduced apoptosis and oxidative stress in myocardial infarction model of Wistar rats[3].
Animal Model: | LPS-Induced Acute Lung Injury Model in C57BL/6 mice (male, 8-10 weeks old)[2] |
Dosage: | 10 μg/kg (dissolved in 0.01% DMSO (PBS) |
Administration: | Intraperitoneal injection, 30 min after LPS chanllenge (7.5 mg/kg; ip; single dose) |
Result: | Reduced neutrophil infiltration (50% decrease), MPO activity (40% decrease), and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in lungs. Restored vascular permeability (Evans blue extravasation reduced by 35%), and inhibited apoptotic cell death (TUNEL-positive cells decreased by 45%). Suppressed NF-κB activation with reduced IkB-α degradation and p65 phosphorylation. |
Animal Model: | Wistar rats (male, 4 months old) + MI via coronary artery ligation[3] |
Dosage: | 10 mg/kg (dissolved in DMSO) |
Administration: | Intraperitoneal injection, single dose immediately after MI induction |
Result: | Improved cardiac function (FS increased by 25%, EDD/ESD reduced by 15%), decreased apoptotic cardiomyocytes (TUNEL-positive cells reduced by 40%), and suppressed cleaved caspase-3 and PARP1 expression. Oxidative stress markers (O2-, nitrotyrosine) were reduced by 30-40% in infarcted myocardium. |
IC 50
PARP-1
References
[1] Meli E, et al. Differential role of poly (ADP-ribose) polymerase-1in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro. Mol Cell Neurosci. 2004;25 (1) :172-180. DOI:10.1016/j.mcn.2003.09.016
[2] Wang G, et al. PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response. PLoS One. 2013 Nov 21;8 (11) :e79757. DOI:10.1371/journal.pone.0079757
[3] Wang J, et al. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Mol Med Rep. 2015 Mar;11 (3) :1768-76. DOI:10.3892/mmr.2014.2977
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDESupplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 571-89925085
- sales@amadischem.com
- Tel
- 15971444841
- amber@biochempartner.com
- Tel
- 0531-58897130 15508676053
- drug_impurity@sdcclh.com
- Tel
- +1-781-999-5354 +1-00000000000
- marketing@targetmol.com
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE(84050-22-6)Related Product Information
- 2-Piperazine-4-amino-6,7-dimethoxyquinazoline
- Terazosin impurity
- 1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone
- Prazosin hydrochloride
- Piperazine, 1-[[(2R)-tetrahydro-2-furanyl]carbonyl]- (9CI)
- Terazosin hydrochloride dihydrate
- [4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-Methyl-2-furanyl]Methanone
- 1-(2-Furoyl)piperazine
- NSC 351869
- [4-(4-AMino-7-hydroxy-6-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone
- Terazosin EP IMpurity D
- 6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one
- 2,2'-(1,4-Piperazinediyl)bis[6,7-diMethoxy-4-quinazolinaMine]
- (R)-Terazosin
- 2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-diMethoxybenzoic Acid (Donepezil IMpurity)
- Terazosin IMpurity J
- [4-(4-AMino-6-hydroxy-7-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone
- Terazosin EP Impurity O